|Articles|September 15, 2016

Walgreens & HHS Provide Uninsured Americans with $10 Million Worth of Free Flu Shot Vouchers

Author(s)Kristi Rosa

Walgreens has partnered up again with the US Department of Health in an effort to improve rates of flu vaccination by providing over $10 million in free flu shot vouchers for Americans who are uninsured.

During this flu season, Walgreens, in a collaborative effort with the US Department of Health and Human Services (HHS), to improve rates of flu vaccination, announced that they will be providing over $10 million in free flu shot vouchers for Americans who are uninsured, according to a recent press release.

J. Nadine Gracia, MD MSCE, deputy assistant secretary for minority health and director of the HHS Office of Minority Health, commented, “Since 2010, this partnership has helped us make substantial strides in addressing disparities in flu vaccination coverage by providing free flu shots for more than 1.4 million people. As the flu season approaches, our continued collaboration will help protect hundreds of thousands of people from influenza, which can make chronic health problems worse or lead to hospitalization or even death.”

Influenza is a respiratory illness that can range in symptoms from mild to severe. Severe cases of influenza can result in hospitalization or even death, according to the Centers for Disease Control and Prevention (CDC). Although the severity of the flu varies by season, the CDC reports that, “millions of people are sickened, hundreds of thousands are hospitalized and thousands or tens of thousands of people die from flu every year,” which makes taking appropriate preventive measures, such as vaccination, even more important.

Through the use of “a variety of outreach efforts, local events and community and faith-based organizations nationwide,” Walgreens and the HHS are distributing the free flu shot vouchers. These vouchers allow for one flu shot to be administered to each uninsured individual at any Walgreens pharmacy (in the United States, Puerto Rico, and US Virgin Islands), Duane Read pharmacy, and Walgreens Healthcare Clinic locations. Walgreens urges those who qualify for the free vouchers to call 866-994-6757 to find a location near them where these vouchers may be available.

Walgreens' president of pharmacy and retail operations, Richard Ashworth, said, “We’re proud to continue to grow our collaboration with HHS and to be working together to meet the health care needs of the communities we serve. We know that cost can be a barrier for some people when it comes to vaccination and other preventive care. And by providing access to flu shots at no cost for those eligible, we can make a significant impact by protecting more people throughout the flu season.”

According to the CDC, the ultimate protection against acquiring influenza is vaccination, but there preventive efforts that can be taken, including avoiding any kind of close contact with those who exhibits symptoms, staying home when sick in order to prevent transmitting the illness to others, covering your cough or sneeze with tissues, performing good hand hygiene using soap and water, and avoiding touching your eyes, mouth, or nose to avoid contamination.


Related to this article

Pfizer 25-Valent Pneumococcal Vaccine Boosts Serotype 3 Response in Infants
Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.
Measles Update: October 30, 2026
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
Measles Update: October 23, 2026
The latest CDC numbers show a 4.0% increase in measles cases from week-to-week, bringing the 2026 US total to 4588 confirmed cases. Ninety-six percent of cases are outbreak-associated.
Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.